Don’t miss this opportunity to explore the intriguing world of computer-guided drug design as we compare two innovative methodologies: fragment-based drug design and full molecule-based drug design. Our esteemed panelists will delve into these two approaches’ strengths, limitations, and future prospects while uncovering potential synergies.